Hematological and surgical data according to presence of bleeding complication
| . | Bleeding complication . | No bleeding complication . | P . |
|---|---|---|---|
| 33 | 219 | ||
| Laboratory values before delivery/procedure | |||
| FXI (U/dL) | 41.5 [14.0-52.0] | 49.0 [40.0-57.3] | .03 |
| Activated PTT (sec) | 32.8 [29.9-41.8] | 31.0 [28.7-34.2] | .03 |
| Hemoglobin (g/dL) | 12.0 [11.3-13.0] | 12.3 [11.6-13.3] | .2 |
| Platelets (109/L) | 186 [152-240] | 199 [173-232] | .3 |
| Blood loss during delivery/procedure (mL) | 659 [213-1000] | 286 [124-400] | <.001 |
| Blood loss following delivery/procedure (mL) | 58 [0-809] | 0 [0-36] | <.001 |
| Hemoglobin decrease following delivery/procedure (g/dL) | 2.8 [1.3-3.5] | 1.6 [1.0-2.6] | .003 |
| Procedure type | .006 | ||
| Vaginal delivery | 11 (33.3) | 132 (60.3) | |
| Cesarean delivery | 15 (45.5) | 48 (21.9) | |
| Other surgical procedure | 7 (21.2) | 39 (17.8) | |
| Hemostatic interventions | |||
| Prophylactic FFP | 8 (24.2) | 13 (5.9) | .002 |
| Prophylactic TXA | 1 (3.0) | 6 (2.8) | .9 |
| Prophylactic RBC | 0 | 2 (0.1) | .8 |
| Nonprophylactic FFP | 10 (30.3) | 0 | <.001 |
| Nonprophylactic TXA | 9 (27.3) | 0 | <.001 |
| Nonprophylactic RBC | 8 (24.2) | 0 | <.001 |
| . | Bleeding complication . | No bleeding complication . | P . |
|---|---|---|---|
| 33 | 219 | ||
| Laboratory values before delivery/procedure | |||
| FXI (U/dL) | 41.5 [14.0-52.0] | 49.0 [40.0-57.3] | .03 |
| Activated PTT (sec) | 32.8 [29.9-41.8] | 31.0 [28.7-34.2] | .03 |
| Hemoglobin (g/dL) | 12.0 [11.3-13.0] | 12.3 [11.6-13.3] | .2 |
| Platelets (109/L) | 186 [152-240] | 199 [173-232] | .3 |
| Blood loss during delivery/procedure (mL) | 659 [213-1000] | 286 [124-400] | <.001 |
| Blood loss following delivery/procedure (mL) | 58 [0-809] | 0 [0-36] | <.001 |
| Hemoglobin decrease following delivery/procedure (g/dL) | 2.8 [1.3-3.5] | 1.6 [1.0-2.6] | .003 |
| Procedure type | .006 | ||
| Vaginal delivery | 11 (33.3) | 132 (60.3) | |
| Cesarean delivery | 15 (45.5) | 48 (21.9) | |
| Other surgical procedure | 7 (21.2) | 39 (17.8) | |
| Hemostatic interventions | |||
| Prophylactic FFP | 8 (24.2) | 13 (5.9) | .002 |
| Prophylactic TXA | 1 (3.0) | 6 (2.8) | .9 |
| Prophylactic RBC | 0 | 2 (0.1) | .8 |
| Nonprophylactic FFP | 10 (30.3) | 0 | <.001 |
| Nonprophylactic TXA | 9 (27.3) | 0 | <.001 |
| Nonprophylactic RBC | 8 (24.2) | 0 | <.001 |
Data are presented as count (percentage) or median [interquartile range].